Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Simultaneous quantification of antibody-RNA conjugates and the transcriptome by single cell RNA-sequencing

ABSTRACT: Simultaneous quantification of antibody-RNA conjugates and the transcriptome by single cell RNA-sequencing

PROVIDER: PRJNA476555 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID

Project description:Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID

| PRJNA476554 | ENA

Simultaneous quantification of antibody-RNA conjugates and the transcriptome by single cell RNA-sequencing

Project description:Undifferentiated and differentiated Keratinocytes (AG1478 treated) were stained with antibody-RNA conjugates (targeting EGFR and ITGA6) to measure protein-based differentiation changes in conjunction with single-cell transcriptomics.

2019-02-13 | GSE115936 | GEO

Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID

Project description:Undifferentiated and differentiated Keratinocytes (AG1478 treated) were stained with antibody-RNA conjugates to measure protein-based diffrentiation changes in conjunction with single-cell transcriptomics. The cells were crosslinked and stained according to the RAID procedure to allow intracellular immunostaining. Antibodies used in this experiment are (TGM1, NOTCH1, KLK6, JAG1, phospho-RPS6, phospho-FAK).

2019-02-13 | GSE115937 | GEO

Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity

Project description:Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity

| PRJNA663153 | ENA

Simultaneous characterisation of RNA and protein subcellular dynamics

Project description:Existing methods to analyse RNA localisation are constrained to specific RNAs or subcellular niches, precluding the cell-wide mapping of RNA. We present Localisation of RNA (LoRNA), which maps, at once, RNAs to membranous (nucleus, ER and mitochondria) and membraneless compartments (cytosol, nucleolus and phase-separated granules). Simultaneous interrogation of all RNA locations allows the system-wide quantification of RNA proportional distribution and the comprehensive analysis of RNA subcellular dynamics. Moreover, we have re-engineered the LOPIT (Localisation Of Proteins by Isotope Tagging) method, enabling integration with LoRNA, to jointly map RNA and protein subcellular localisation. Applying this framework, we obtain a global re-localisation map for 31839 transcripts and 5314 proteins during the unfolded protein response, uncovering that ER-localised transcripts are more efficiently recruited to stress granules than cytosolic RNAs, and revealing eIF3d is key to sustain cytoskeletal function. Overall, we provide the most exhaustive map to date of RNA and protein subcellular dynamics.

2022-01-25 | PXD030456 | Pride

Low-input RNase footprinting for simultaneous quantification of cytosolic and mitochondrial translation

Project description:Low-input RNase footprinting for simultaneous quantification of cytosolic and mitochondrial translation

| PRJNA638017 | ENA

Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity II

Project description:Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity II

| PRJNA663155 | ENA

Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity I

Project description:Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity I

| PRJNA662959 | ENA

Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates

Project description:Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates

| PRJNA545736 | ENA

Immune-stimulating antibody conjugates elicit robust myeloid activation and durable anti-tumor immunity II

Project description:Innate pattern recognition receptors, including toll-like receptors (TLRs), can alter the tumor microenvironment and prime adaptive anti-tumor immunity. However, TLR agonists have not been well-tolerated due to toxicities associated with widespread immune activation following systemic administration. To design a therapeutic that is suitable for systemic delivery and capable of eliciting a tumor-targeted response, we developed a novel class of immune-stimulating antibody conjugates (ISACs) comprising a TLR7/8 agonist conjugated to tumor-targeting antibodies. Systemically administered anti-HER2 ISACs were well-tolerated in vivo and elicited robust activation of intratumoral myeloid cells, resulting in tumor clearance and subsequent immunological memory. In vitro potency and in vivo efficacy required tandem activity driven by intact Fc functionality and TLR agonism to enable phagocytosis and T cell-mediated anti-tumor immunity. ISAC-mediated immunological memory was not limited to HER2, as ISAC-treated mice were protected from rechallenge with a HER2-negative tumor. These results provide strong rationale for the clinical development of ISACs and show that synergy between FcgR and TLR7/8 signaling contributes to the mechanism of ISAC-mediated anti-tumor immunity.

2020-12-03 | GSE157869 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data